Healthcare Reimbursement Explained for Startup Founders
Healthcare reimbursement is how a health product actually gets paid for, and it runs on three linked questions: coding (what service are you billing?), coverage (has a payer agreed to pay for it?), and payment (how much, and through what workflow?). Map all three before you build. A great product with no reimbursement path is a hobby, not a business.
Quick Answer: Reimbursement = coding + coverage + payment. Before you build, confirm there is a billable code for what you do, a payer willing to cover it, and a payment rate that clears your cost to deliver. If any one leg is missing, you do not have a business model yet — you have a science project.
A note before we start: reimbursement rules below are US-centric. Payer systems, codes, and coverage processes differ substantially in other countries, so verify the specifics for the market you actually sell into.
Why reimbursement shapes digital health business models
Reimbursement decides who pays, how predictably, and how much — and those three facts cascade into your pricing power, your sales cycle, your unit economics, and how much clinical evidence you need before anyone will scale with you. In most industries the person who uses the product is the person who pays for it. Healthcare breaks that assumption.
In a reimbursed health business, the user, the decider, and the payer are usually three different parties. A patient uses the product. A clinician prescribes or orders it. And an insurer, employer, or government program writes the check. The "who pays" question — the reimbursement question — sits upstream of almost every other decision you will make.
That is why founders who skip it get blindsided. You can build something patients love and clinicians endorse, and still have no way to get paid at scale, because no payer recognizes the service you deliver. Understanding how to validate a healthtech startup idea starts with this exact question: not "will people want it?" but "who pays, and will they?"
Reimbursement strategy also sets your evidence bar. Cash-pay products can launch on a compelling promise. Payer-covered products generally cannot — payers want proof that a service improves outcomes or lowers total cost, which is a much higher bar than a landing-page conversion. The category of proof payers require from digital health companies is different in kind from the metrics that satisfy a consumer growth team, and pretending otherwise is how good products stall.
For a venture-track founder, reimbursement is also a valuation story. Investors who fund health companies read a clear, defensible reimbursement path as evidence that revenue can compound instead of stalling at the edge of early-adopter demand. A vague answer here reads as unpriced risk, and it shows up in your terms — or in a passed deal. The reimbursement question is not only how you get paid; it is how sophisticated capital decides whether your market is real.
The practical takeaway: reimbursement is not a finance detail you hand off later. It is a core product and go-to-market constraint that should shape what you build from day one.
The four channels money reaches a health product
There is no single "insurance pays for it" pathway. Money reaches a health product through four distinct channels, and each one carries its own buyer, sales cycle, evidence bar, and failure mode. Most founders should pick one to lead with, not chase all four at once.
The four channels are:
- Fee-for-service — a payer reimburses a discrete billable service each time it is delivered.
- Value-based care — you get paid for outcomes or shared savings, often through a risk-bearing partner, rather than per service.
- Cash-pay (direct-to-consumer) — the patient pays out of pocket, no payer involved.
- Employer-paid — a self-insured employer or benefits buyer purchases your product for its population.
Here is how those channels compare across the dimensions that actually decide whether you can build a company on them:
| Channel | Who writes the check | How you get paid | Typical sales cycle | Evidence bar | Best fit for |
|---|---|---|---|---|---|
| Fee-for-service | Commercial insurer, Medicare, Medicaid | Per billable service, via claims | Long (coding + coverage first) | High — coverage policy usually needs clinical proof | Services that map to a recognized billable act |
| Value-based care | Risk-bearing provider group, health plan, ACO-type entity | Outcomes, shared savings, or capitation | Long, relationship-driven | Very high — must show total-cost or outcome impact | Products that measurably reduce downstream cost |
| Cash-pay | The patient | Direct payment at point of sale | Short — you control it | Market/consumer evidence, not clinical coverage | Consumer wellness, elective, convenience |
| Employer-paid | Self-insured employer / benefits buyer | Contract, often per-member-per-month | Medium — procurement-driven | ROI and engagement evidence | Population health, prevention, benefits add-ons |
The takeaway: cash-pay is the fastest path to revenue and the one you control, but it caps your addressable market at people willing to pay out of pocket. Insurance and value-based channels unlock far larger markets and stickier economics, but they demand evidence, coding, and patience most early-stage teams underestimate. Many successful health startups start cash-pay to prove demand, then use that traction and early outcome data to earn their way into payer channels.
One more thing about these channels: they are not mutually exclusive forever, but they are hard to run in parallel early. Each has a different buyer, a different sales motion, and a different proof it demands, so a seed-stage team splitting focus across all four usually does none of them well. Choose the channel your evidence and runway can actually support now, and treat the others as a roadmap, not a launch plan.
The reimbursement path step by step
The reimbursement path has four stages, and you clear them roughly in order: get a code for what you do, secure coverage from a payer, confirm the payment rate clears your cost, and build the billing workflow that makes the money actually collectible. Skipping ahead is the classic mistake — a code with no coverage pays nothing, and coverage with a broken billing workflow pays late or not at all.
Step 1: Coding — find (or create) the code for what you do
Coding is how you describe your service in the standardized language payers and clinicians use to communicate. In the US, the most familiar set is CPT (Current Procedural Terminology), maintained by the American Medical Association; there is also HCPCS, maintained by the Centers for Medicare & Medicaid Services (CMS), which covers items and services CPT does not.
A code is not payment. It is a label that makes your service legible to the billing system. If a code that fits what you do already exists, you are in a much stronger position — you can point to it. If nothing fits, you may be looking at creating a new code, which is a formal, multi-year process, not a form you fill out.
One nuance worth knowing early: CPT has categories, and emerging-technology services often land in the temporary tracking category rather than a permanent, reliably-paid one. Temporary codes exist to gather usage data, and payment against them is frequently discretionary. If you want the mechanics of how these codes are structured and why the category matters, start with what a CPT code is and how it works before you assume a code guarantees revenue.
The founder question here is blunt: is there an existing code that credibly describes my service, or am I betting the company on creating one?
Step 2: Coverage — getting a payer to say yes
Coverage is a payer's decision that it will pay for a service for a defined patient population under defined conditions. A code can exist while coverage does not — the two are separate gates. This is where many founders discover their real timeline.
Payers publish coverage positions in policy documents. For government programs these show up as national and local coverage determinations; commercial insurers each maintain their own medical policies. A service is only reimbursable to the extent a specific payer has agreed to cover it, and payers do not move in unison — you can be covered by one plan and denied by the next.
Coverage decisions typically hinge on evidence that the service is medically necessary and improves outcomes or reduces cost. Some services also require prior authorization, meaning the payer must approve before delivery. Expect coverage to be won payer-by-payer, and expect the first few to be the hardest.
There is also a strategic choice hidden in coverage: which payer you pursue first. Winning coverage from a large, influential plan can create momentum others follow, but those plans are also the hardest to move and the slowest to decide. Some teams instead target a smaller, motivated payer or a self-insured employer as a beachhead, generate real-world results, and use that evidence to approach larger plans. Sequencing your coverage strategy is as consequential as the evidence you bring to it.
Step 3: Payment rate — confirming the number clears your cost
The payment rate is the actual dollar amount a payer allows for a covered, coded service — and it is the step that quietly kills otherwise-viable ideas. A service can be coded and covered but reimbursed at a rate below what it costs you to deliver. That is not a business; it is a subsidy you are paying.
Rates vary by payer, by geography, by care setting, and over time, so do not anchor on a single published number. The discipline is to model your fully-loaded cost to deliver one unit — clinician time, technology, support, overhead — and compare it against the realistic allowed amount, net of denials and the share of claims that never get paid.
Rates also move for reasons outside your control — periodic payer updates, policy changes, and shifts in how one service is valued relative to others. Build your model with headroom, because a path that only pencils at today's exact rate is fragile against the next adjustment.
Because I cannot responsibly quote specific rates that shift constantly and differ by region, treat any figure you find as a starting point to verify with people who bill in your specialty today, not as a fixed input.
Step 4: Billing workflow — making the money collectible
The billing workflow is the operational machinery that turns an approved service into cash in your account, and it is where reimbursement stops being theory. You need clean documentation, correct claim submission, and a process for handling denials and appeals — because a meaningful share of claims are denied on first submission and only paid after rework.
This is the revenue-cycle reality that finance-light founding teams miss. The unit economics you modeled in Step 3 only hold if you can submit clean claims and collect on them without burning margin on rework. If collecting the money requires heroic manual effort per claim, your beautiful reimbursement path leaks cash at the last mile.
How to test a reimbursement path before building
You can validate a reimbursement path with interviews and desk research long before you write a line of product code — and you absolutely should, because the cost of being wrong here is measured in years. Reimbursement is one of the most researchable risks in a health startup, precisely because payers publish policies and billers live this every day.
Work through these tests in order, from cheapest to most involved:
- Read the coverage policies yourself. Pull the medical policies of the payers you would sell to and the coverage determinations for government programs. If no policy addresses a service like yours, that absence is a finding, not a gap to gloss over.
- Interview people who bill for a living. Revenue-cycle managers, medical billers, and practice administrators know which codes get paid, which get denied, and which are more trouble than they are worth. They will puncture optimistic assumptions faster than anyone.
- Talk to a payer's medical or network side. Even an informal conversation reveals what evidence they would need to see and how they think about a service like yours. Frame it as learning, not selling.
- Trace one hypothetical claim end to end. Pick a real patient scenario and walk it through code, coverage, rate, documentation, submission, and collection. Every place it breaks is a risk to resolve before building.
- Pressure-test the economics against denials. Model your rate net of realistic denial and non-collection rates, not the gross allowed amount. If it only works at 100% clean collection, it does not work.
These conversations are structured customer-discovery interviews aimed at the payer side of your market, and the same discipline that governs any rigorous end-to-end startup idea validation process applies here: ask about what people actually do and have paid for, not what they say they might approve in theory. A tool like Edmired exists to keep that evidence organized, but the core move is simply talking to the right people before you commit capital.
None of this requires a built product. It requires a list of the right people, a set of honest questions, and the discipline to treat a discouraging answer as valuable rather than something to argue past. Founders who do this well often end up reshaping what they deliver so it maps onto a service payers already recognize and pay for. That is not a compromise; it is the reimbursement path informing the product, which is exactly the order you want.
The goal is a defensible answer to one question: if we build this, is there a realistic path by which someone pays us enough, reliably enough, to make a business?
Reimbursement mistakes that kill health startups
The most damaging reimbursement mistakes share a root cause: treating payment as a later problem instead of a founding constraint. By the time the money problem surfaces, the product is built and the runway is short. Here are the failure patterns that recur most often.
- Assuming a code equals income. A code makes you billable; it does not make you paid. Founders who find a plausible code and stop there routinely discover there is no coverage behind it, or the rate is uneconomic.
- Confusing "a payer covered it once" with "payers cover this." Coverage is fragmented across plans and geographies. One favorable policy is a data point, not a market.
- Modeling gross rates, ignoring denials. The number that matters is what you collect after denials, appeals, and write-offs — not the headline allowed amount.
- Building for reimbursement that does not exist yet. Betting the company on a not-yet-created code, or on a future coverage decision, is a real strategy for some teams — but only if you go in with eyes open about the multi-year timeline and fund accordingly.
- Under-resourcing the billing workflow. Great coverage with a broken revenue cycle still starves the business. The last mile of collection is where modeled margin evaporates.
- Designing the product before the reimbursement path. When the billable service and the product are shaped independently, they rarely line up cleanly, and you end up retrofitting one to the other.
The through-line: every one of these is cheaper to catch in a research phase than to discover after launch.
Key Takeaways
- Reimbursement is three questions, not one. Coding, coverage, and payment are separate gates — clearing one tells you nothing about the other two, and you need all three to have a business model.
- The user, the decider, and the payer are usually different parties. Healthcare breaks the ordinary assumption that the person using a product is the one paying for it, and that gap is the reimbursement problem in a sentence.
- Cash-pay is fast and controllable; insurance is large and slow. Many health startups start cash-pay to prove demand, then use early traction and outcome data to earn their way into payer channels.
- A code is a label, not a payment. Existing codes strengthen your position; needing a brand-new one usually means a multi-year process you must fund deliberately.
- Coverage is won payer-by-payer. No single favorable policy makes a market, and government and commercial payers reach their own decisions on their own evidence.
- Model rates net of denials, not gross. The dollar that matters is what you actually collect after denials, appeals, and write-offs — a clean-claim fantasy hides a broken business.
- Reimbursement is one of the most researchable risks you have. Payer policies are public and billers live this daily, so you can validate the path through interviews and desk research before building anything.
Frequently Asked Questions
How does healthcare reimbursement actually work?
Reimbursement works in three linked stages. First, a service is described with a standardized code so the billing system recognizes it. Second, a payer decides whether it covers that service for a given patient population. Third, if covered, the payer pays an allowed rate, which you collect through a claims and denials workflow. All three must line up for money to arrive.
Do I need a CPT code to sell a digital health product?
Not always — it depends on your channel. Cash-pay and many employer-paid products do not route through insurance claims at all, so no code is required. But if you want commercial insurers or government programs to reimburse your service, you generally need a code that describes it plus a payer that covers it. Decide your channel first, then whether coding applies.
What is the difference between having a code and getting paid?
A code makes your service billable; getting paid requires coverage and an economic rate on top of that code. Think of the code as a label the system recognizes, coverage as a payer agreeing to pay for that labeled service, and the rate as whether the amount clears your cost. A code with no coverage, or coverage at a losing rate, produces zero usable revenue.
How long does it take to get a new digital health service reimbursed?
Longer than most founders plan for — often years when a new code or new coverage decision is involved. Using an existing, well-covered code shortens the path dramatically, while creating a new code and then building coverage payer-by-payer is a multi-year effort. This is exactly why you research the reimbursement path before building, not after.
Should my health startup go cash-pay or pursue insurance reimbursement?
Start with whichever channel matches your evidence and urgency. Cash-pay gets you to revenue fast, keeps you in control, and validates demand — but caps your market at people willing to pay out of pocket. Insurance and value-based channels reach far larger populations with stickier economics, at the cost of evidence requirements and long timelines. A common sequence is cash-pay first, payer channels once you have outcome data.
Are these reimbursement rules the same outside the United States?
No. The coding-coverage-payment framework is a useful mental model in many systems, but the specific codes, payers, coverage processes, and single-payer or national-health structures vary widely by country. Everything here reflects the US context. If you sell into another market, verify the local reimbursement mechanics with someone who operates in that system before you rely on any of it.